Fluid management during continuous renal replacement therapy (CRRT) in critically ill patients is a dynamic process that encompasses 3 inter-related goals: maintenance of the patency of the CRRT circuit, maintenance of plasma electrolyte and acid-base homeostasis and regulation of patient fluid balance. In this article, we report the consensus recommendations of the 2016 Acute Disease Quality Initiative XVII conference on ‘Precision Fluid Management in CRRT'. We discuss the principles of fluid management, describe various prescription methods to achieve circuit integrity and introduce the concept of integrated fluid balance for tailoring fluid balance to the needs of the individual patient. We suggest that these recommendations could serve to develop the best clinical practice and standards of care for fluid management in patients undergoing CRRT. Finally, we identify and highlight areas of uncertainty in fluid management and set an agenda for future research.

Keywords:
Fluid, Management, Continuous renal replacement therapy, Precision medicine, Hemodialysis
1.
Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, et al: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008;358:877-887.
2.
Rosner MH, Ostermann M, Murugan R, Prowle JR, Ronco C, Kellum JA, et al: Indications and management of mechanical fluid removal in critical illness. Br J Anaesth 2014;113:764-771.
3.
Kellum JA, Mehta RL, Angus DC, Palevsky P, Ronco C; ADQI Workgroup: The first international consensus conference on continuous renal replacement therapy. Kidney Int 2002;62:1855-1863.
4.
Gibney N, Cerda J, Davenport A, Ramirez J, Singbartl K, Leblanc M, et al: Volume management by renal replacement therapy in acute kidney injury. Int J Artif Organs 2008;31:145-155.
5.
Bouchard J, Mehta RL: Volume management in continuous renal replacement therapy. Semin Dial 2009;22:146-150.
6.
Bihorac A, Ross EA: Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition. Am J Kidney Dis 2005;46:908-918.
7.
Tolwani A, Wille KM: Advances in continuous renal replacement therapy: citrate anticoagulation update. Blood Purif 2012;34:88-93.
8.
Joannidis M, Oudemans-van Straaten HM: Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care 2007;11:218.
9.
Macedo E, Mehta RL: Continuous dialysis therapies: core curriculum 2016. Am J Kidney Dis 2016;pii:S0272-6386(16)30097-X.
10.
de Pont AC, Bouman CS, Bakhtiari K, Schaap MC, Nieuwland R, Sturk A, et al: Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis. ASAIO J 2006;52:416-422.
11.
van der Voort PH, Gerritsen RT, Kuiper MA, Egbers PH, Kingma WP, Boerma EC: Filter run time in CVVH: pre- versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation. Blood Purif 2005;23:175-180.
12.
Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract 2003;94:c94-c98.
13.
Davenport A: Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis 2001;37:457-466.
14.
Han SS, Bae E, Kim DK, Kim YS, Han JS, Joo KW: Dysnatremia, its correction, and mortality in patients undergoing continuous renal replacement therapy: a prospective observational study. BMC Nephrol 2016;17:2.
15.
Kraus MA: Selection of dialysate and replacement fluids and management of electrolyte and acid-base disturbances. Semin Dial 2009;22:137-140.
16.
Morabito S, Pistolesi V, Tritapepe L, Fiaccadori E: Regional citrate anticoagulation for RRTs in critically ill patients with AKI. Clin J Am Soc Nephrol 2014;9:2173-2188.
17.
Zhang L, Chen Z, Diao Y, Yang Y, Fu P: Associations of fluid overload with mortality and kidney recovery in patients with acute kidney injury: a systematic review and meta-analysis. J Crit Care 2015;30:860.e7-e13.
18.
Malbrain ML, Marik PE, Witters I, Cordemans C, Kirkpatrick AW, Roberts DJ, et al: Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther 2014;46:361-380.
19.
O'Connor ME, Prowle JR: Fluid overload. Crit Care Clin 2015;31:803-821.
20.
Davies H, Leslie GD, Morgan D: A retrospective review of fluid balance control in CRRT. Aust Crit Care 2016;pii:S1036-7314(16)30037-30036.
21.
Xu J, Ding X, Fang Y, Shen B, Liu Z, Zou J, et al: New, goal-directed approach to renal replacement therapy improves acute kidney injury treatment after cardiac surgery. J Cardiothorac Surg 2014;9:103.
22.
Hoste EA, Maitland K, Brudney CS, Mehta R, Vincent JL, Yates D, et al: Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth 2014;113:740-747.
23.
Daugirdas JT: Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001;38(4 suppl 4):S11-S17.
24.
Flythe JE, Kimmel SE, Brunelli SM: Rapid fluid removal during dialysis is associated with cardiovascular morbidity and mortality. Kidney Int 2011;79:250-257.
25.
Rabindranath K, Adams J, Macleod AM, et al: Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007;3:CD003773.
26.
Schneider AG, Bellomo R, Bagshaw SM, Glassford NJ, Lo S, Jun M, et al: Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med 2013;39:987-997.
27.
Xu J, Shen B, Fang Y, Liu Z, Zou J, Liu L, et al: Postoperative fluid overload is a useful predictor of the short-term outcome of renal replacement therapy for acute kidney injury after cardiac surgery. Medicine (Baltimore) 2015;94:e1360.
28.
Claure-Del Granado R, Bouchard J: Acid-base and electrolyte abnormalities during renal support for acute kidney injury: recognition and management. Blood Purif 2012;34:186-193.
29.
Dangoisse C, Dickie H, Tovey L, Ostermann M: Correction of hyper- and hyponatraemia during continuous renal replacement therapy. Nephron Clin Pract 2014;128:394-398.
30.
Sigler MH: Transport characteristics of the slow therapies: implications for achieving adequacy of dialysis in acute renal failure. Adv Ren Replace Ther 1997;4:68-80.
31.
Kalantari K, Chang JN, Ronco C, Rosner MH: Assessment of intravascular volume status and volume responsiveness in critically ill patients. Kidney Int 2013;83:1017-1028.
32.
Huang Z, Letteri JJ, Ronco C, Gao R, Clark WR: Predilution and postdilution reinfusion techniques; in Ronco C, Bellomo R, Kellum J (eds): Critical Care Nephrology, ed 2. Saunders, 2009, pp 1370-1374.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.